Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form;Traitement dun enfant autiste par la naltrexone

Encephale

Volumn 35, Issue 2, 2009, Pages 168-172

  Desjardins, S ^a   Doyen, C ^a   Contejean, Y ^a   Kaye, K ^a   Paubel, P ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

Autism; Children; Naltrexone; Therapeutic alternative

Indexed keywords

BUSPIRONE; CLOMIPRAMINE; CYAMEMAZINE; CYANOCOBALAMIN; HALOPERIDOL; LITHIUM; NALTREXONE; PERICIAZINE; PSYCHOTROPIC AGENT; PYRIDOXINE; RISPERIDONE; THIORIDAZINE; VALPROIC ACID; NARCOTIC ANTAGONIST;

AGGRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; AUTOMUTILATION; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CLINICAL ASSESSMENT; COGNITIVE REHABILITATION; COGNITIVE THERAPY; COMMUNICATION DISORDER; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG MARKETING; EDUCATIONAL TECHNOLOGY; HEALTH PROGRAM; HOSPITAL; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MENTAL DEFICIENCY; MENTAL INSTABILITY; MOTOR DYSFUNCTION; OUTCOME ASSESSMENT; PARENTAL CONSENT; PRESCRIPTION; PSYCHOEDUCATION; PSYCHOLOGIC ASSESSMENT; PSYCHOMOTOR ACTIVITY; PSYCHOTHERAPY; SCALE UP; SEDATION; SIDE EFFECT; SLEEP DISORDER; SOCIAL ADAPTATION; SPAIN; SPEECH THERAPY; SUSPENSION; SYMPTOM; TABLET FORMULATION; TREATMENT OUTCOME; TREATMENT PLANNING; CHILD; EDUCATION; FRANCE; MALE; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PATIENT CARE; PHYSIOTHERAPY; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR DISORDER;

ADMINISTRATION, ORAL; AUTISTIC DISORDER; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; EDUCATION, SPECIAL; FRANCE; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PATIENT CARE TEAM; PHYSICAL THERAPY MODALITIES; PSYCHOMOTOR DISORDERS; SPEECH THERAPY; SUSPENSIONS; TREATMENT OUTCOME;

EID: 67349096423     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2008.01.004     Document Type: Article

References (21)

1. M.G. Aman , and K.S. Langworthy Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders J Autism Dev Disord 30 2000 451 459
2. A. Baghdadli , V. Gonnier , and C. Aussilloux Review of psychopharmacological treatments in adolescents and adults with autistic disorders Encéphale 28 2002 248 254
3. O. Brunet , and I. Lezine Le developpement psychomoteur de la petite enfance : présentation dune échelle française pour examen des tout petits, Collection Bibliothèqye Scientifique Internationale, Sciences humaines, section psychologie 1965 PUF Paris
4. N. Chabane , M. Leboyer , and M.C. Mouren-Simeoni Opiate antagonists in children and adolescents Eur Child Adolesc Psychiatry 9 Suppl. 1 2000 I44 I50
5. E.H. Cook , and B.L. Leventhal The serotonin system in autism Curr Opin Pediatr 8 1996 348 354 (Pubitemid 26393877)
6. H.M. Feldman , B.K. Kolmen , and A.M. Gonzaga Naltrexone and communication skills in young children with autism J Am Acad Child Adolesc Psychiatry 38 1999 587 593 (Pubitemid 29203475)
7. C.H. Goyette , C.K. Conners , and R.F. Ulrich Normative data on revised Conners Parent and Teacher Rating Scales J Abnorm Child Psychol 6 1978 221 236
8. B.K. Kolmen , H.M. Feldman , and B.L. Handen Naltrexone in young autistic children: replication study and learning measures J Am Acad Child Adolesc Psychiatry 36 1997 1570 1578 (Pubitemid 27461104)
9. K.S. Lam , M.G. Aman , and L.E. Arnold Neurochemical correlates of autistic disorder. A review of the literature Res Dev Disabil 27 2006 254 289
10. M. Leboyer , M.P. Bouvard , and M. Dugas Effects on naltrexone on infantile autism Lancet 1 1988 715 (Pubitemid 18083310)
11. M. Leboyer , M.P. Bouvard , and C. Recasens Difference between plasma N- and C-terminally directed beta-endorphin immunoreactivity in infantile autism Am J Psychiatry 151 1994 1797 1801 (Pubitemid 24370902)
12. A. Philippe , M. Martinez , and Guilloud-Bataille Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study Hum Mol Genet 8 1999 805 812
13. C.A. Sandman Beta-endorphin disregulation in autistic and self-injurious behavior: a neurodevelopmental hypothesis Synapse 2 1988 193 199 (Pubitemid 18165507)
14. C.A. Sandman , J.L. Barron , and Chicz-DeMet Brief report: plasma beta-endorphin and cortisol levels in autistic patients J Autism Dev Disord 21 1991 83 87
15. E. Schople , R.J. Reicheler , and B. Rochen-Renner The Childhood Autism Rating, Scale (CARS) 1988 Western Psychological Services Los Angeles, CA
16. Schopler E., Reichler R.J. Individualized assessment and treatment for autistic and developementally disabled children. Psychoeducational profile (2nd ed.), vol 1 Traduit : Profil psychoéducatif (PEP-R). Bruxelles: De Boeck Bruxelles, 1979.
17. F.J. Symons , A. Thompson , and M.C. Rodriguez Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis Ment Retard Dev Disabil Res Rev 10 2004 193 200 (Pubitemid 40095894)
18. M.J. Tasse , M.G. Aman , and D. Hammer The Nisonger Child Behavior Rating Form: age and gender effects and norms Res Dev Disabil 17 1996 59 75 (Pubitemid 26030824)
19. T. White , and S.K. Schultz Naltrexone treatment for a 3-year-old boy with self-injurious behavior Am J Psychiatry 157 2000 1574 1582
20. P.G. Williams , A. Allard , and L. Sears A.S. Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management J Autism Dev Disord 31 2001 103 108 (Pubitemid 37486132)
21. World Health Organization. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva, 1992. CIM-10/ ICD-10 Troubles mentaux et troubles du comportement: descriptions cliniques et directives pour le diagnostic, trad. Fr. Pull C.B. et al. Paris: Masson, 1993.